Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc.

RNAC

Classement en actions #18423
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides... Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company’s lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.
Prix de l'action
$6.27
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$189.70M
Changement (1 jour)
-4.71%
Changement (1 an)
839.61%
Pays
US
Échange Cartesian Therapeutics, Inc. (RNAC)

Catégorie

Healthcare
Le prix RNAC avec la capitalisation boursière de B
Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc.
RNAC
$6.27
Capitalisation boursière de Cartesian Therapeutics, Inc.(RNAC)
Capitalisation boursière: $189.70M
En October 2026, Cartesian Therapeutics, Inc. a une capitalisation boursière de $189.70M. Cela fait de Cartesian Therapeutics, Inc. la 18423rd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Cartesian Therapeutics, Inc. du 2016 au 2026
RNAC par rapport au top 5 des plus populaires stocks
Prix pour RNAC L’actif B La capitalisation boursière de B Résultats
Selecta Biosciences, Inc. Selecta Biosciences, Inc.
$35,421.04 $97.34M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.167T +5,308,013.01%
Selecta Biosciences, Inc. Selecta Biosciences, Inc.
$34,377.26 $97.34M
Apple Inc. Apple Inc.
AAPL
$5.015T +5,151,595.07%
Selecta Biosciences, Inc. Selecta Biosciences, Inc.
$28,163.88 $97.34M
Alphabet Inc. Alphabet Inc.
GOOG
$4.108T +4,220,471.80%
Selecta Biosciences, Inc. Selecta Biosciences, Inc.
$26,748.29 $97.34M
Microsoft Corporation Microsoft Corporation
MSFT
$3.902T +4,008,335.41%
Selecta Biosciences, Inc. Selecta Biosciences, Inc.
$18,436.73 $97.34M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.689T +2,762,784.86%